RecruitingNot applicableNCT06990659
Outpatient Versus Inpatient Care Pathway for Intra-arterial Treatment of Primary Liver Cancer (CHOC)
Studying Rare malignant epithelial tumor of liver and intrahepatic biliary tract
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Angers
- Principal Investigator
- Christophe AUBE, PrUniversity Hospital, Angers
- Intervention
- Ambulatory care(other)
- Enrollment
- 206 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2028
Study locations (14)
- University hospital of Amiens, Amiens, France
- University hospital of Angers, Angers, France
- University hospital of Besançon, Besançon, France
- Hospital of Avicennes (AP-HP), Bobigny, France
- University hospital of Brest, Brest, France
- Hospital of Beaujon (AP-HP), Clichy, France
- Hospital of Vendée, La Roche-sur-Yon, France
- University hospital of Grenoble-Alpes, La Tronche, France
- University hospital of Montpellier, Montpellier, France
- University hospital of Nice, Nice, France
- Hospital of Pitié-Salpétrière (AP-HP), Paris, France
- Hospital of Cochin (AP-HP), Paris, France
- Univesity hospital of Bordeaux, Pessac, France
- Institut Gustave Roussy (IGR), Villejuif, France
Collaborators
Université Paris Cité
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06990659 on ClinicalTrials.govOther trials for Rare malignant epithelial tumor of liver and intrahepatic biliary tract
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07146646Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract CancerCase Comprehensive Cancer Center
- RECRUITINGPHASE2NCT06529718Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer PatientsUNICANCER
- RECRUITINGNCT07142226Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTCCHA University
- RECRUITINGNCT07151118ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract CancerCHA University
- RECRUITINGPHASE2NCT07135544A Single-arm, Multicenter, Exploratory Study of Adebrelimab Combined With Apatinib and Systemic Chemotherapy for Initially Unresectable Biliary Tract CancerYongjun Chen
- RECRUITINGNCT06793709A Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene Positivity Who Progressed After ChemotherapyEisai Co., Ltd.
- RECRUITINGPHASE1, PHASE2NCT06708663HX009+ IN10018 with or Without Standard Chemotherapy for Advanced Solid TumoursHangzhou Hanx Biopharmaceuticals, Ltd.
- RECRUITINGNCT06653127Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Biliary Tract Cancer Recurrence SurveillanceTongji Hospital
See all trials for Rare malignant epithelial tumor of liver and intrahepatic biliary tract →